Moderna's CMV trial offers further upside - UBS
Go back to Moderna's CMV trial offers further upside - UBS| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.81 +0.64 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.17 | 52 Week High | $0.52 | |||
| Open | $59.75 | 52 Week Low | $0.08 | |||
| Day High | $60.77 | P/E | N/A | |||
| Day Low | $58.41 | EPS | $-3.80 | |||
| Volume | 6,238,810 | |||||

